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ABSTRACT 
MR-guided radiotherapy treatment planning utilises the high soft-tissue contrast of 
MRI to reduce uncertainty in delineation of the target and organs at risk. Replacing 
4D-CT with MRI-derived synthetic 4D-CT would support treatment plan adaptation 
on hybrid MR-guided radiotherapy systems for inter- and intrafractional differences in 
anatomy and respiration, whilst mitigating the risk of CT to MRI registration errors. 
Three methods were devised to calculate synthetic 4D and midposition (time-
weighted mean position of the respiratory cycle) CT from 4D-T1w and Dixon MRI. 
The first approach employed intensity-based segmentation of Dixon MRI for bulk-
density assignment (sCTD). The second step added spine density information using 
an atlas of CT and Dixon MRI (sCTDS). The third iteration used a polynomial function 
relating Hounsfield units and normalised T1w image intensity to account for variable 
lung density (sCTDSL).  Motion information in 4D-T1w MRI was applied to generate 
synthetic CT in midposition and in twenty respiratory phases. For six lung cancer 
patients, synthetic 4D-CT was validated against 4D-CT in midposition by comparison 
of Hounsfield units and dose-volume metrics. Dosimetric differences found by 
comparing sCTD,DS,DSL and CT were evaluated using a Wilcoxon signed-rank test (p 
= 0.05). 
Compared to sCTD and sCTDS, planning on sCTDSL significantly reduced absolute 
dosimetric differences in the planning target volume metrics to less than 98 cGy (1.7 
% of the prescribed dose) on average. When comparing sCTDSL and CT, average 
radiodensity differences were within 97 Hounsfield units and dosimetric differences 
were significant only for the planning target volume D99 % metric. All methods 
produced clinically acceptable results for the organs at risk in accordance with the 
UK SABR consensus guidelines and the LungTech EORTC phase II trial. The overall 
good agreement between sCTDSL and CT demonstrates the feasibility of employing 
synthetic 4D-CT for plan adaptation on hybrid MR-guided radiotherapy systems. 
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INTRODUCTION 
Magnetic resonance guided radiotherapy (MRgRT) exploits the high soft-tissue 
contrast of magnetic resonance imaging (MRI) to improve treatment delivery in 
radiotherapy (Lagendijk et al., 2014; Schmidt and Payne, 2015). Computed 
tomography (CT) images can be registered to magnetic resonance (MR) images to 
optimise radiotherapy treatment planning (RTP); electron density information from 
the CT images are employed for dose calculations and MR images are used to 
facilitate target and organ at risk (OAR) delineation (Owrangi et al., 2018). 
Registration can result in systematic errors that propagate through the workflow and 
have been reported to be 2-5 mm for the brain and prostate (Edmund and Nyholm, 
2017). Registration errors, between CT and MRI, can be eliminated by deriving 
synthetic CT (sCT) from MRI (Johnstone et al., 2018).  
In conventional radiotherapy workflows, treatment delivery is based on the same pre-
treatment CT image for all fractions, which is problematic as the patient anatomy 
might change during the course of treatment, for instance because of tumour 
shrinkage. Dosimetric errors related to inter- and intrafractional differences in 
anatomy can be reduced when delivering adaptive MRgRT (Lagendijk et al., 2014; 
Raaymakers et al., 2009; Kontaxis et al., 2017; Mutic and Dempsey, 2014; Thwaites 
et al., 2014; Fallone, 2014). In this scenario, treatment plans can be updated with the 
online patient anatomy and position obtained using sCT acquired during a hybrid 
MRgRT treatment session. Calculation of sCT by registering the pre-treatment CT 
image to daily MRI acquired prior to each treatment fraction was demonstrated 
(Kraus et al., 2017). However, generating sCT directly from MRI is more desirable 
because it would eliminate registration errors and simplify the radiotherapy workflow 
by reducing the total number of scans (Edmund and Nyholm, 2017). 
Alternatively, sCT has been calculated using bulk-density assignment, atlas-based, 
voxel-based (including machine learning) and hybrid methods, with the majority of 
approaches applied to relatively immobile sites, such as the brain or prostate 
(Johnstone et al., 2018; Edmund and Nyholm, 2017). In the abdominothoracic 
region, most current methods are based on tissue-segmentation and bulk-density 
assignment. Of the methods which do not include bone-density information, 
dosimetric differences of the D95 % metric (dose delivered to at least 95 % of the 
planning target volume (PTV)) between sCT and CT have been reported to be less 
than 1 % using 3D conformal RTP (Jonsson et al., 2010), and greater than 5 % using 
volumetric modulated arc therapy (VMAT) RTP (Prior et al., 2017). In methods which 
include bone-density information, for instance by using an anterior vertebral body 
model (VMAT RTP) (Bredfeldt et al., 2017) or an atlas (intensity modulated RTP) 
(Wang et al., 2017), mean dosimetric differences for all regions and metrics have 
been reported to be within 1 %. 
There is scope to improve abdominothoracic sCT. (Prior et al., 2017) demonstrated 
that incorrect bulk-density assignment in the lung leads to errors up to 19.6 % in the 
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PTV dose-volume metrics. Patient specific lung electron density values should 
therefore be implemented to account for underlying lung pathology (Soejima et al., 
2000; Rosenblum et al., 1980; Durham and Adcock, 2015). Furthermore, four-
dimensional (4D) or midposition (MidP) (time-weighted mean position of the 
respiratory cycle) (Wolthaus et al., 2008a) sCT might be employed to account for 
respiratory motion in dose reconstruction (Al‐Ward et al., 2018).  
In this article, thoracic 4D/MidP-sCT was calculated using three different methods 
and validated dosimetrically against the corresponding MidP image of 4D-CT for plan 
adaptation on MRgRT systems. In the first method, 4D/MidP-sCT was obtained 
using tissue-segmentation and bulk-density assignment (sCTD), and was extended in 
the second method using an atlas to include bone-density information (sCTDS). The 
third method employed a fitting approach to account for variable lung density 
(sCTDSL). 
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MATERIALS AND METHODS 
Data Acquisition 
Six patients with early stage non-small cell lung cancer (5 adenocarcinoma, 1 mixed 
adenosquamous carcinoma), all of whom were treated with stereotactic 
radiotherapy, were included in this study after giving written informed consent. A 4D-
CT scan was obtained for all patients using a Brilliance Big Bore CT scanner at 
120kV (Philips Medical Systems, Best, The Netherlands), with voxel-size (0.98 x 
0.98 – 1.17 x1.17) x 2 mm3 and ten respiratory phases. Within a median of 2 (range: 
0-14) days, MRI was acquired at 1.5 Tesla (MAGNETOM Aera; Siemens Healthcare, 
Erlangen, Germany) using a golden-angle radial T1-weighted stack-of-stars spoiled 
gradient echo sequence (Block et al., 2014) in free breathing and a Cartesian 2-point 
Dixon gradient echo sequence in exhalation. Patients unable to breath-hold were 
scanned in free-breathing with four averages, resulting in an image close to 
exhalation. Patients were scanned in the same treatment position in both MRI and 
CT acquisition, which was enabled using an MR compatible immobilisation board 
(Extended Wing Board; Civco Radiotherapy, Coralville, IA, USA). During MR 
acquisition, an in-house built body coil holder was used to prevent compression of 
the body contour by the 18-channel receive array. Detailed MRI acquisition 
parameters can be found in Table 1. 
TABLE 1. Detailed acquisition parameters. No, number; Acq, acquisition; NA, not 
applicable. 
Parameter 
Radial T1w 
stack-of-stars 
Dixon 
(exhalation) 
Dixon 
 (free-breathing) 
Orientation Axial Axial Axial 
No. slices 80 - 88 64 - 88 72 – 88 
No. spokes 1005 NA NA 
Acq. time, min 05:19 – 05:45 00:20 – 00:21 02:02 - 02:49 
Field of view, mm2 
  320 x 320 –  
336 x 336 
  322 x 430 – 
360 x 480 
  312 x 400 – 
368 x 469 
Voxel-size, mm3 
(1.25 x 1.25 - 
1.31 x 1.31) x 3.5 
(1.68 x 1.68 - 
1.88 x 1.88) x 4.2 
(1.25 x 1.25 – 
1.34 x 1.34) x 3.5 
Echo time, ms 1.55 2.39, 4.77 2.39, 4.77 
Repetition time, ms 3.18 7.6 7.6 
Flip angle, degree 8 8 8 
Pixel bandwidth, Hz 630 400 400 
No. signal averages 1 1 4 
Fat suppression 
 
YES 
 
NO 
 
NO 
 
 
 
 
Page 5 of 24 AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
c i
pt
4D-sCT for MRgRT 
6 
 
Reconstruction of T1w Data 
T1w MRI was reconstructed using the 4D joint motion-compensated high-
dimensional total variation (4D joint MoCo-HDTV) algorithm (Rank et al., 2017). Prior 
to reconstruction, the raw data were corrected with an adaptive gradient-delay 
compensation (Block and Uecker, 2011) and sorted into 20 overlapping respiratory 
phases using a self-gating signal based on the k-space centre (Paul et al., 2015). 
After reconstruction, a 3D geometrical distortion correction was applied to each 
respiratory phase to account for gradient non-linearity, using the spherical harmonic 
coefficients provided by the vendor (Doran et al., 2005). More details regarding the 
reconstruction workflow can be found in (Freedman et al., 2017). 
Motion-modelling 
All of the following calculations were carried out in MATLAB (version 2017a; The 
Mathworks, Natik, MA) on an Intel Xeon E5-1660 processor with 8 cores at 3 GHz 
and 64 GB of memory. Key components of the following motion-modelling method 
are provided in Figure 1: A. 
Based on volumetric normalised mutual information (NMI) (Pluim et al., 2003), the 
closest matching respiratory phase of 4D-T1w MRI (𝑇1𝑗) was chosen with respect to 
the in-phase Dixon image (𝐷𝑗). Deformation vector fields (DVFs) were calculated by 
non-rigidly registering 𝑇1𝑗 to all 𝑛 remaining respiratory phases (𝐷𝑉𝐹𝑇𝑗→𝑇𝑛). All b-
spline GPU accelerated non-rigid registrations were carried out using NiftyReg 
(Modat et al., 2010). A chain method concatenating DVFs was employed to reduce 
errors resulting from large deformations (Freedman et al., 2017). The transformation 
𝐷𝑉𝐹𝑇𝑗→𝑇𝑀𝑖𝑑𝑃 from the closest matching phase to MidP was determined from the 
𝐷𝑉𝐹𝑇𝑗→𝑇𝑛 set (Wolthaus et al., 2008a). MidP-T1w MRI was obtained by applying 
𝐷𝑉𝐹𝑇𝑗→𝑇𝑀𝑖𝑑𝑃 to 𝑇1𝑗. 𝐷𝑉𝐹𝐷𝑗→𝑇𝑗 was generated by non-rigidly registering 𝐷𝑗 to 𝑇1𝑗. 
Water, fat and in-phase Dixon images were warped to MidP using the composition: 
𝐷𝑉𝐹𝑇𝑗→𝑇𝑀𝑖𝑑𝑃 ∗ 𝐷𝑉𝐹𝐷𝑗→𝑇𝑗. 
MidP-CT was independently calculated from 4D-CT in the same way that MidP-T1w 
MRI was obtained from 4D-T1w MRI. 
Atlas 
The atlas contained MidP-T1w, MidP-Dixon (fat, water and in-phase), MidP-CT and 
MidP-spine (segmented from MidP-CT) images. The MidP-CT atlas images were 
obtained by registering the pre-calculated MidP-CT images to the MidP in-phase 
images. The MidP-spine atlas images were extracted from the MidP-CT atlas images 
using a thresholding and region of interest (ROI) method (Figure 1: B): 
Bone was segmented from MidP-CT by thresholding (125 to 1500 Hounsfield units 
(HU)) and connected component analysis; the first connected component 
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corresponded to the rib cage, which includes the thoracic vertebrae. Stray pixels 
were removed by morphologically dilating and closing the rib cage image using an 
ellipsoid structuring element (1,1, 2 pixels). A rectangular ROI was manually placed 
around the spine on the central axial slice of the processed rib cage image. Pixels 
outside the ROI were set to zero on all slices. Holes were filled using a 
morphological flood-fill operation (Soille, 1999).  
A leave-one-out cross-validation was enabled by truncating the atlas to include all 
acquired data except the patient for which MidP-sCT was being generated (referred 
to as the incoming patient or image). 
Dixon Synthetic CT (sCTD)  
MidP-sCT (sCTD) was generated from the MidP-Dixon images using intensity-based 
segmentation and assignment of HU for fat (-110), soft-tissue (70), air (-1000) and 
lung (-767). HU values were chosen from (Wang et al., 2017). Segmentation was 
carried out using binary masks: 
A binary mask 𝑀 (background and lungs = 1, remaining = 0) was calculated by 
thresholding the summed MidP-Fat and MidP-Water images. Thresholds were set as 
the mean summed image intensity. 𝑀 was zero padded and subjected to connected 
component analysis; the largest component was the background mask 𝐵. The lung 
mask 𝐿 was calculated as 𝑀 − 𝐵. 
Fat and water masks were initialised by applying the |1 − 𝑀| mask to the MidP-Fat 
and MidP-Water images. The initialised fat mask was thresholded using the mean 
non-zero intensity of the MidP-Fat image and then post-processed, to reduce stray 
pixels and holes, by keeping only the largest connected component. The post-
processed fat mask was applied to remove fat components from the initialised water 
mask.  
Dixon-Spine Synthetic CT (sCTDS) 
sCTD were updated to include spine density information (sCTDS) from the best-
matching MidP-spine atlas image. All MidP-Fat atlas images were registered to the 
incoming MidP-Fat image. The corresponding MidP-spine atlas images were warped 
with the resulting transformations and applied to segment the spine of registered 
MidP-Fat images. NMI was calculated between the incoming and registered 
segmented MidP-Fat images. The MidP-spine atlas image corresponding to the 
best-matching registered segmented MidP-Fat image (highest NMI) was fused with 
sCTD by intensity override. 
Dixon-Spine-Lung Synthetic CT (sCTDSL) 
sCTDS were modified to include variable lung density information (sCTDSL). The 
relationship between signal intensity in MidP-T1w images and HUs of co-registered 
MidP-CT images was modelled in the lung with a fifth order polynomial (Figure 1: C). 
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MidP-T1w images were corrected for intensity inhomogeneity (Hofmann et al., 2011): 
First the scanner-reconstructed T1w images were passed through 3D median and 
image guided filters (He et al., 2013). MidP-T1w images were then divided by the 
filtered scanner-reconstructed images. Afterwards, inhomogeneity corrected MidP-
T1w images were normalised such that the mean intensity values of the water 
components in each image were equal. Ten million non-zero points were randomly 
selected in the lungs of MidP-T1w MRI and MidP-CT. Data support over the entire 
intensity range was assured by further sorting the data into 20 equal sized bins, and 
then extracting 5000 random data points from each bin. The polynomial weights 
were then obtained by linear least squares fitting to the selected data.  
In order to enable a leave-one-out cross-validation, the truncated MidP atlas (see 
Materials and Methods: Atlas) data were used to calculate separate polynomial 
weights for each incoming patient. Variable lung density information was included by 
applying the fitted polynomial to incoming MidP-T1w intensity values. A summary of 
sCTDSL generation can be found in Figure 1: D. 
For incoming patient 2 it was necessary to generate additional sCT images by 
linearly scaling the lung HU values of sCTD,DS,DSL to match the median lung CT HU 
value (-865 HU). Scaling was required because patient 2 exhibited co-existent lung 
disease (severe emphysema) and did not fit into the group of other patients, which 
exhibited a mean (over patients 1 and 3-6) median HU value of -808. 
Four-dimensional sCT was calculated by warping MidP-sCT to all other respiratory 
phases using the composition of the 𝐷𝑉𝐹𝑇𝑗→𝑇𝑛  and inverse 
𝐷𝑉𝐹𝑇𝑗→𝑇𝑀𝑖𝑑𝑃  transformations (for DVF calculations, see Materials and Methods: 
Motion-modelling).  
 
 
 
 
 
 
 
 
 
 
Page 8 of 24AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
4D-sCT for MRgRT 
9 
 
Figure 1: A, the transformation from the 𝑗𝑡ℎ respiratory phase to midposition (MidP) 
of 4D-T1w MRI is calculated (𝐷𝑉𝐹𝑇𝑗→𝑇𝑀𝑖𝑑𝑃). MidP-Dixon MRI is obtained by 
composing the DVF found by registering Dixon MRI to the 𝑗𝑡ℎ respiratory phase of 
4D-T1w MRI (𝐷𝑉𝐹𝐷𝑗→𝑇𝑗) with 𝐷𝑉𝐹𝑇𝑗→𝑇𝑀𝑖𝑑𝑃. B, describes the key steps involved in 
generating the atlas. C, describes polynomial fitting. The data used to ascertain the 
polynomial coefficients (5 patients) were obtained from the atlas. D, synthetic MidP-
CT is calculated with a tissue-segmentation and bulk-density assignment method 
(sCTD), updated with non-rigidly registered spine-density information from the best-
matching atlas image set (sCTDS), and variable lung density information using the 
fitting method (sCTDSL). 𝐷𝑉𝐹𝐷𝑀𝑖𝑑𝑃→𝐷𝑀𝑖𝑑𝑃
′  describes the transformation of each atlas 
MidP-Dixon (fat) MRI to the incoming MidP-Dixon (fat) MRI; (𝐷𝑉𝐹𝐷𝑀𝑖𝑑𝑃→𝐷𝑀𝑖𝑑𝑃
′ )
𝐵𝑒𝑠𝑡
 
describes transformation of the best-matching MidP-spine image to incoming MidP 
MRI. 
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Synthetic CT: Validation 
MidP-sCT images were validated by comparison to MidP-CT, both dosimetrically and 
in terms of HUs. Radiation oncologists performed delineation and treatment 
planning. Using the information from non-rigidly registered MidP-T1w and MidP-
Dixon images, one set of contours was generated for the primary tumour and OARs 
for each patient. The contours represented the “best fit” between CT and MR 
images. Single full arc coplanar stereotactic VMAT plans at 6 MV were designed for 
all patients using a collapse cone algorithm and an Agility multileaf collimator on 
RayStation (v5.99, RaySearch Laboratories, Sweden) with a dose grid voxel-size of 
2.5 mm and collimator angle of 2 º. Five patients had peripheral lesions with a PTV 
close to the chest wall, and were planned according to the UK SABR consortium 
guidelines with a five fraction regimen (55 Gy in 5 fractions) using the constraints 
stipulated in a recent UK SABR consensus publication (Hanna et al., 2018). One 
patient had a central lesion and was planned using an eight fraction regimen (60 Gy 
in 8 fractions) as per the LungTech EORTC phase II trial protocol (Adebahr et al., 
2015; Lambrecht et al., 2016). As MidP images were used, PTV margins were 
personalised for each patient, and this was dependent on tumour motion. PTV 
margins were calculated using motion information from the 4D-T1w images, but 
applying the same principles as reported elsewhere using 4D-CT planning (Wolthaus 
et al., 2008b). Once contours had been finalised, they were copied onto the fused 
sCT images. Two planning techniques were used: initial planning on MidP-CT and 
independent re-calculation on sCTD,DS,DSL (Plan 1); and initial planning on sCTD,DS,DSL 
(using all sCT methods independently) and re-calculation on MidP-CT (Plan 2). 
Differences in the following dose-volume metrics were compared: Dose delivered to 
at least 95 or 99 % of the PTV (PTV D95 or 99 % respectively), total PTV volume 
divided by the total isodose volume of interest (Conformity Index at Isodose), volume 
of lung receiving ≥ 20 Gy (v20 Gy), Proximal Airways near-point maximum dose 
(Dmax), which was defined as minimum dose to the 0.5 cm3 volume of the organ 
receiving the highest dose (Hanna et al., 2018), Oesophagus Dmax 0.5 cm3, 
Brachial Plexus Dmax 0.5 cm3, Heart Dmax 0.5 cm3, Spinal Canal Dmax 0.1 cm3, 
and Chest Wall D 30 cm3, which is defined as the minimum dose to 30 cm3 of the 
organ that receives the highest dose. In an exploratory analysis, a Wilcoxon signed-
rank test with a significance level of p = 0.05 was applied to evaluate the dosimetric 
differences found by comparing sCTD,DS,DSL and CT. Using the same analysis, the 
absolute values of the above-mentioned dosimetric differences were compared for 
significance between methods (sCTDDS, sCTDSDSL, sCTDDSL).  
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RESULTS 
For six patients with early stage node negative primary lung malignancies, three 
variations of MidP-sCT (sCTD,DS,DSL) were calculated. For these patients, mean PTV 
volume was 34 (range: 22 – 40) cm3. Four-dimensional T1w MRI reconstruction took 
between 9 and 12 hours, and calculation of sCTD, sCTDS and sCTDSL was finished in 
30, 51 and 54 minutes, respectively. Figure 2 shows an example reconstructed 
MidP-CT compared to sCTD,DS,DSL. sCTDSL provided good visual agreement with 
MidP-CT, due to not only comparable spine and variable lung density, but also 
matching respiratory phase. Two example movies of 4D-sCT (sCTDSL, 20 respiratory 
phases) for patients 1 and 4 are provided as Supplemental Material. 
 
Figure 2: A comparison of Dixon (sCTD), Dixon-Spine (sCTDS) and Dixon-Spine-Lung 
(sCTDSL) synthetic CT to midposition CT for patient 4. sCT is windowed (Soft-
tissue/Bone/Lung) to optimally display the new information that was introduced in 
each consecutive method. 
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Validation: Hounsfield Units 
The median and standard deviation of the absolute differences in HUs, over all 
patients, between CT and sCT of the Dixon and Dixon-Spine-Lung methods were: 43 
± 187 and 42 ± 188 for the soft-tissue region, 43 ± 146 and 40 ± 144 for the fat 
region, 71 ± 114 and 43 ± 106 for the lung region, and 174 ± 186 and 96 ± 161 for 
the spine region; demonstrating that overall sCTDSL exhibited the highest similarity 
with the ground-truth CT images (Figure 3).  
 
Figure 3: Regional comparison of Hounsfield unit (HU) in CT and synthetic CT (sCT) 
images. Boxplots summarise the HU distributions of each segmented region (fat, 
soft-tissue, spine and lung) for all patients; shading distinguishes between data 
obtained from CT (shaded) and sCT (unshaded) images. Filled black circles depict 
the bulk-assigned HU values of sCTD. Outliers in the data, determined as 1.5 times 
the interquartile range above the upper quartile or below the lower quartile, were 
removed for display. Due to the variability in both the spine and lung densities, HU 
values of CT best matched sCTDSL.   
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Validation: Dose-volume Metrics 
As presented in Figure 4, differences in selected dose-volume metrics between 
sCTD,DS,DSL and CT were significant for PTV metrics, but not for OAR metrics. Unlike 
sCTD and sCTDS, sCTDSL only exhibited a significant difference for the PTV D99 % 
metric (p = 0.03) of Plan 2 (planned on sCT and re-calculated on CT). For the PTV 
D95 % and D99 % metrics, sCTDSL exhibited the lowest absolute difference with CT, 
which was (mean ± standard deviation in %) 1.7 ± 2.5 and 1.4 ± 2.3 for Plan 1 
(initially planned on CT and re-calculated on sCT), and 1.6 ± 2.4 and 1.7 ± 2.2 for 
Plan 2. The mean and standard deviations were skewed by the results of patient 2, 
which exhibited absolute differences up to 6.7 %. If the lung HU value of patient 2 
was linearly scaled to match the median lung HU value of CT (Figure 4; black 
diamonds), the average absolute differences of the PTV D95 % and D99 % metrics 
were reduced to: 0.91 ± 0.89 and 0.77 ± 1.1 for Plan 1, and 0.77 ± 0.93 and 1.0 ± 1.1 
for Plan 2. The average absolute differences (over all patients) of the investigated 
dose-volume metrics between sCTDSL and CT are summarised in Table 2. For the 
OAR dose-volume metrics, minor differences were observed, but did not violate pre-
defined clinical goals. 
Comparison of Synthetic CT Method 
Significant reductions in absolute differences were found for the PTV D95 % 
(sCTDDS, sCTDSDSL and sCTDDSL) and Conformity Index at Isodose metrics 
(sCTDSDSL and sCTDDSL) of Plan 1, and for the PTV D95 % (sCTDDSL and 
sCTDSDSL) and D99 % metrics (sCTDSDSL) of Plan 2. For all OAR metrics, except 
the Proximal Airways Dmax 0.5 cm3 metric, the mean absolute dosimetric difference 
over all patients decreased between sCTD and sCTDSL. No significant absolute 
differences were found for the OAR metrics. 
Figure 5 displays an example illustrating the differences between the three sCT 
methods. Compared to sCTD, inclusion of spine density information in sCTDS resulted 
in a reduction of local hot spots in the differences between the simulated dose 
distributions of sCT and CT. Inclusion of variable lung density in sCTDSL led to a 
further reduction in dose differences. In particular, the appearance of hot spots 
around the PTV decreased.  
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Figure 4: Differences in selected dose-volume metrics between the three methods of 
synthetic CT (sCT) and CT. AD,DS,DSL denotes planning on CT and re-calculating on 
the sCTD,DS,DSL images (Plan 1). BD,DS,DSL codifies planning on the sCTD,DS,DSL 
images and re-calculating on CT (Plan 2). Coloured circles encode patient number 
(red, blue, green, orange, yellow and brown codify patients 1 to 6, respectively). 
Black diamonds show the results of re-planning patient 2 (blue) with rescaled lung 
HUs. Black crosses show significant differences between sCT and CT; brackets and 
stars label significant absolute differences between sCT methods. Mandatory clinical 
goals for the five patients planned with 55 Gy in 5 fractions are listed on the top left-
hand side of each subplot. 
 
Page 14 of 24AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
4D-sCT for MRgRT 
15 
 
TABLE 2. Absolute (abs) differences (diff) between sCTDSL and CT 
Metric 
Plan 1 
(abs diff) 
Plan 2 
(abs diff) 
Plan 1 
(% diff) 
Plan 2 
(% diff) 
Spinal Canal 20 ± 18 (cGy) 19 ± 22 (cGy) 1.2 ± 0.8 1.2 ± 1.1 
Lung v20 Gy 0.06 ± 0.10 (%) 0.07 ± 0.08 (%) 1.1 ± 1.7 1.3 ± 16 
Proximal 
Airways  
11 ± 12 (cGy) 25 ± 26 (cGy) 2.2 ± 3.3 3.1 ± 3.9 
Oesophagus  21 ± 13 (cGy) 23 ± 16 (cGy) 1.3 ± 0.6 1.3 ± 0.8 
Brachial 
Plexus 
10 ± 17 (cGy) 8 ± 16 (cGy) 1.9 ± 2.9 1.4 ± 3.4 
Heart 30 ± 32 (cGy) 31 ± 30 (cGy) 1.7 ± 1.0 3.0 ± 2.7 
Chest Wall 29 ± 20 (cGy) 28 ± 17 (cGy) 1.0 ± 0.7 1.0 ± 0.6 
Conformity 
Index 
0.03 ± 0.05 (0-1) 0.02 ± 0.03 (0-1) 3.9 ± 6.3 2.5 ± 2.8 
PTV D95 % 96 ± 135 (cGy) 85 ± 123 (cGy) 1.7 ± 2.5 1.6 ± 2.4 
PTV D99 % 77 ± 119 (cGy) 84 ± 108 (cGy) 1.4 ± 2.3 1.7 ± 2.2 
Table 2: The mean and standard deviation absolute differences (abs diff) between 
the Dixon-Spine-Lung sCT method (sCTDSL) and CT for the: Spinal Canal Dmax 0.1 
cm3, Lung v20 Gy, Proximal Airways Dmax 0.5 cm3, Oesophagus Dmax 0.5 cm3, 
Brachial Plexus Dmax 0.5 cm3, Heart Dmax 0.5 cm3, Chest wall D 30 cm3, 
Conformity Index at Isodose, PTV D95 % and PTV D99 % dose-volume metrics. 
Differences were taken with respect to CT for both Plans 1 (planned on CT and re-
calculated on sCTDSL) and 2 (planned on sCTDSL and re-calculated on CT), and did 
not include the rescaled sCT of patient 2. 
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Figure 5: An example dosimetric comparison as planned on each of the three 
midposition synthetic CT images (sCTD,DS,DSL) and evaluated on the midposition CT 
(patient 4). First and second rows: simulated dose planned on sCT and re-evaluated 
on CT. Third row: differences between the first and second rows. The planning target 
and gross tumour volumes are contoured in dashed white and yellow lines. White 
arrows assist viewing of an example hot spot reduction when comparing successive 
sCT methods. Fourth row: zoom-in of the region indicated by the white arrows. 
Overall, differences in the simulated dose-distributions are reduced with consecutive 
sCT method. 
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Discussion 
In this article, three methods to calculate 4D-sCT were introduced and validated in 
MidP against 4D-CT. Employing 4D/MidP-sCT on hybrid MRgRT systems would 
enable plans to be adapted for anatomical differences and changes in respiratory 
pattern throughout the course of radiotherapy treatment, which might permit target 
dose boosting and sparing OARs (Al‐Ward et al., 2018), whilst mitigating the risk of 
registration errors between CT and MRI. Moreover, 4D-sCT could be combined with 
motion information from fast 2D cine MRI to obtain a patient-specific motion-model 
(Stemkens et al., 2016), which might be applied to generate low-latency volumetric 
sCT. In the comparison of HUs and dose-volume metrics sCTDSL exhibited the 
greatest agreement with MidP-CT, which was due to inclusion of variable spine and 
lung density. For Plan 2, the most clinically relevant scenario (planned on sCT and 
evaluated on CT), no significant differences were found between dose-volume 
metrics of sCTDSL and CT, except for the PTV D99 % metric. Furthermore, absolute 
differences between sCTDSL and CT for the PTV D95 % and D99 % metrics were on 
average less than 1.7 %. For sCTDSL, dose to OAR metrics varied over patients, but 
did not violate pre-defined clinical goals. The overall agreement suggests that 
sCTDSL would enable plan adaptation on hybrid MRgRT systems for lung cancer 
patients. Further work is required to improve the methodology for patients with 
underlying pathology causing high variability in lung density.  
Compared to sCTD, employing sCTDS resulted in a reduction of the median and 
standard deviation HU errors in the spine by 78 and 25 HUs. Furthermore a 
significant dosimetric error reduction in the PTV D95 % metric was obtained between 
sCTD and sCTDS for Plan 1. Inclusion of variable spine density was shown to 
decrease local hot spots in the differences between the simulated dose distributions 
of CT and sCT (Figure 5), which might explain the reductions in HUs and dose-
volume metric values. A reduction in the median and standard deviation lung HU 
error of 28 and 8 HUs was calculated between sCTD and sCTDSL, which was 
complemented by a significant reduction of absolute dose differences in the PTV 
metrics for Plans 1 and 2. The reported sensitivity of the PTV metrics to the assigned 
lung HUs was corroborated by (Prior et al., 2017), who showed that the difference in 
the PTV D95 % metric can vary up to 9.06 % (target population average) when 
assigning bulk lung electron densities between 0.1 – 0.5 gcm-3.   
For patient 2, lung HU values of sCTD,DS,DSL were scaled to match the median lung 
HU value of CT. For the PTV D95 % metric, scaled sCTD and sCTDSL displayed 
absolute differences of: 122 and 130 cGy for Plan 1; 97 and 132 cGy for Plan 2. 
These differences were lower than corresponding unscaled values for sCTD and 
sCTDSL, which were: 518 and 367 cGy for Plan 1; 544 and 332 cGy for Plan 2 (Figure 
4). On closer imaging review, patient 2 had severe emphysema - a disease which 
causes destruction of the alveolar septa, leaving enlarged air spaces and a loss of 
elastic recoil (Longmore et al., 2014) (see Supplemental Material). Large differences 
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in PTV dose-volume metrics might be explained by low signal-to-noise ratio in the 
lung, which might have led to incorrect assignment of enlarged air spaces as lung 
tissue. As demonstrated for patient 2, scaling of lung HU values to the average value 
on an available CT scan might be employed to correct for enlarged air spaces, 
without introducing registration errors. If no CT scan existed, as in a strict MR-only 
workflow, ultra-short echo time (Ohno et al., 2016) or balanced steady-state free-
precession sequences (Bauman et al., 2009) could be employed to distinguish 
emphysema from healthy lung tissue.  
Dosimetric accuracy of sCT might be affected by scanner and patient-dependent 
geometrical distortions. Patient-dependent distortions are caused by off-resonance 
due to magnetic susceptibility differences between tissues and chemical shift 
(Weygand et al., 2016). (Stanescu et al., 2012) simulated the maximum 
susceptibility-induced field inhomogeneity in the thorax as 5.6 ppm, which 
corresponds for our acquisition to a maximum distortion of 0.90 pixel in the Dixon 
images (pixel bandwidth = 400 Hz). In the T1w images, patient-dependent distortions 
manifest as blurring, due to the radial readout. The impact of minor patient-
dependent distortions in the Dixon images was mitigated by non-rigidly registering to 
the radial T1w images. Alternatively, patient-dependent distortions could be 
corrected for using separately acquired B0 inhomogeneity maps. We corrected for 
scanner-dependent gradient non-linearity induced distortions, but expect residual 
distortions, which increase in magnitude with distance from isocenter (Doran et al., 
2005). (Huang et al., 2016) reported average residual distortion errors within 1.5 mm 
over radial distances up to 200 mm from isocenter. Accuracy of sCT, in particular the 
body contour, is therefore subject to the specified tolerances by the vendor. We 
minimised the impact of residual geometrical distortions in our validation study by 
registering MRI to CT.  
We have presented a precise methodology to generate 4D/MidP-sCT which is 
promising for PTV metrics and clinically acceptable for OAR metrics. However, our 
approach has several drawbacks. Due to the time factor involved in reconstruction of 
4D-T1w MRI, it is not yet feasible for application within the same session as 
acquired; currently limiting its applicability for MRgRT systems. The estimation of 
DVFs based on the 4D-MRI makes our 4D-sCT method independent of the MR 
image reconstruction algorithm. For instance, reconstruction time of 4D-MRI might 
be reduced to a clinical timeframe of 5-10 minutes using a state-of-the-art server 
(Mickevicius and Paulson, 2017). Because of its ease of implementation, a best-atlas 
method was employed for multi-atlas label-fusion when performing spine 
segmentation. Alternative label-fusion techniques, such as majority voting (Iglesias 
and Sabuncu, 2015; Kieselmann et al., 2018) or a two-step local weighting method 
(Arabi et al., 2016), might provide dosimetric improvements related to spine density. 
One limitation of our study is that the static B0 magnetic field was not accounted for 
during treatment planning, which will result in dosimetric uncertainties associated 
with the electron return effect (Raaijmakers et al., 2005). (Menten et al., 2016) 
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compared conventional lung stereotactic treatment plans with and without the 
magnetic field and reported significant dosimetric differences only for the skin OAR, 
which would suggest that our results remain applicable to MRgRT. 
To our knowledge this is the first time that 4D-MRI has been used to calculate and 
verify sCT in the midposition of the respiratory cycle. Employing the MidP image 
results in similar planning margins to idealised gated radiotherapy (Wolthaus et al., 
2008a). Our method also supports generation of 4D-sCT (Supplemental Material: 
Movies 1 and 2); enabling alternative planning images, such as the mid-ventilation 
image (time-averaged position of the respiratory cycle), to be calculated (Wolthaus et 
al., 2008b; Wolthaus et al., 2006). In (Prior et al., 2017), an incorrect lung HU bulk-
assignment was shown to cause errors larger than 5 % in the PTV dose-volume 
metrics. To optimise lung HU assignment, we devised a polynomial fitting method to 
account for variable lung density, which significantly reduced errors in the PTV dose-
volume metrics. The polynomial fitting method is sensitive to intensity inhomogeneity 
resulting from non-uniform receiver coil profiles. We addressed this problem by 
implementing an intensity correction based on the vendor-provided image 
normalisation. A fifth order polynomial was chosen because it well represented the 
function returned using Gaussian Process Regression (Freedman et al., 2018), but 
was faster to train and apply to incoming data. In the presented work, the polynomial 
weights and spine density information were calculated from truncated atlas data, 
which enabled a leave-one-out cross-validation. In clinical practice, the same atlas 
would be employed for all incoming patients. In (Wang et al., 2017), absolute mean 
errors in the PTV dose-volume metrics were reported to be less than 1 %. However 
in (Wang et al., 2017), lung cancer was simulated using homogeneous spherical 
lung lesions in mostly non lung cancer patients. Due to the strong relationship 
between lung cancer and underlying lung pathology (Durham and Adcock, 2015), it 
is possible that the low errors reported in (Wang et al., 2017) are not fully 
representative of actual lung cancer patients, which were the target population in our 
study. 
Conclusion 
Three methods to calculate 4D-sCT were developed and validated on six lung 
cancer patients by comparison with 4D-CT using HUs and dose-volume metrics in 
the midposition of the respiratory cycle. Compared to bulk-density assignment, 
inclusion of variable spine and lung density led to significantly reduced dosimetric 
differences in PTV metrics. For sCT generated using the Dixon-Spine-Lung method, 
dosimetric differences were clinically acceptable for OAR metrics, and for PTV 
metrics were on average ≤ 98 cGy (1.7 %). We have demonstrated the feasibility of 
calculating thoracic 4D-sCT from 4D-T1w and Dixon MRI for treatment plan 
adaptation on hybrid MRgRT systems.  
 
Page 19 of 24 AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
c
ted
 M
nu
cri
pt
4D-sCT for MRgRT 
20 
 
ACKNOWLEDGMENTS 
We thank Siemens Healthineers, in particular Alto Stemmer, for providing us with the 
nonproduct radial MRI sequence and for giving us access to the spherical harmonic 
coefficients of the MAGNETOM Aera. We also thank Nina Tunariu, Dow-Mu Koh and 
Alex Dunlop for their help with data acquisition and image analysis. We acknowledge 
NHS funding to the NIHR Biomedical Research Centre and the Clinical Research 
Facility at The Institute of Cancer Research and The Royal Marsden NHS 
Foundation Trust and the CR UK Cancer Imaging Centre grant C1060/A16464. We 
acknowledge funding from CR UK programme grants C33589/A19727, and project 
grants C347/A18365, C309/A20926 and C7224/A23275. Martin O. Leach is an NIHR 
Emeritus Senior Investigator. 
CONFLICT OF INTEREST 
The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust are 
part of the Elekta MR Linac Research Consortium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 20 of 24AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
4D-sCT for MRgRT 
21 
 
REFERENCES 
Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, De 
Ruysscher D, Peulen H, Belderbos J and Dziadziuszko R 2015 LungTech, an 
EORTC Phase II trial of stereotactic body radiotherapy for centrally located 
lung tumours: a clinical perspective Br J Radiol 88 20150036 
Al‐Ward S M, Kim A, McCann C, Ruschin M, Cheung P, Sahgal A and Keller B M 
2018 The development of a 4D treatment planning methodology to simulate 
the tracking of central lung tumors in an MRI‐linac J Appl Clin Med Phys 19 
145-55 
Arabi H, Koutsouvelis N, Rouzaud M, Miralbell R and Zaidi H 2016 Atlas-guided 
generation of pseudo-CT images for MRI-only and hybrid PET–MRI-guided 
radiotherapy treatment planning Phys Med Biol 61 6531 
Bauman G, Puderbach M, Deimling M, Jellus V, Chefd'hotel C, Dinkel J, Hintze C, 
Kauczor H U and Schad L R 2009 Non‐contrast‐enhanced perfusion and 
ventilation assessment of the human lung by means of fourier decomposition 
in proton MRI Magn Res Med 62 656-64 
Block K and Uecker M 2011 Simple method for adaptive gradient-delay 
compensation in radial MRI ISMRM 19th Annual Meeting & Exhibition  2816 
Block K T, Chandarana H, Milla S, Bruno M, Mulholland T, Fatterpekar G, Hagiwara 
M, Grimm R, Geppert C and Kiefer B 2014 Towards routine clinical use of 
radial stack-of-stars 3d gradient-echo sequences for reducing motion 
sensitivity J Korean Phys Soc 18 87-106 
Bredfeldt J S, Liu L, Feng M, Cao Y and Balter J M 2017 Synthetic CT for MRI-based 
liver stereotactic body radiotherapy treatment planning Phys Med Biol 62 
2922-34 
Doran S J, Charles-Edwards L, Reinsberg S A and Leach M O 2005 A complete 
distortion correction for MR images: I. Gradient warp correction Phys Med Biol 
50 1343-61 
Durham A and Adcock I 2015 The relationship between COPD and lung cancer Lung 
Cancer 90 121-7 
Edmund J M and Nyholm T 2017 A review of substitute CT generation for MRI-only 
radiation therapy Radiat Oncol 12 28 
Fallone B G 2014 The rotating biplanar linac–magnetic resonance imaging system 
Semin Radiat Oncol 24 200-2 
Freedman J, Bainbridge H, Wetscherek A, Collins D, Nill S, Dunlop A, Kachelrieß M, 
Leach M, McDonald F and Oelfke U 2018 PO-0959: Dosimetric Evaluation of 
Midposition Pseudo-CT for MR-only Lung Radiotherapy Treatment planning 
Radiother Oncol 127 S526-S7 
Freedman J N, Collins D J, Bainbridge H, Rank C M, Nill S, Kachelrieß M, Oelfke U, 
Leach M O and Wetscherek A 2017 T2-Weighted 4D Magnetic Resonance 
Imaging for Application in Magnetic Resonance-Guided Radiotherapy 
Treatment Planning Invest Radiol 52 563-73 
Hanna G, Murray L, Patel R, Jain S, Aitken K, Franks K, Van As N, Tree A, Hatfield 
P and Harrow S 2018 UK Consensus on Normal Tissue Dose Constraints for 
Stereotactic Radiotherapy Clin Oncol 30 5-14 
He K, Sun J and Tang X 2013 Guided image filtering IEEE Trans. Pattern Anal. 
Mach. Intell 35 1397-409 
Hofmann M, Bezrukov I, Mantlik F, Aschoff P, Steinke F, Beyer T, Pichler B J and 
Schölkopf B 2011 MRI-based attenuation correction for whole-body PET/MRI: 
Page 21 of 24 AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
ted
 M
an
us
cri
pt
4D-sCT for MRgRT 
22 
 
quantitative evaluation of segmentation-and atlas-based methods J Nucl Med 
52 1392-9 
Huang K C, Cao Y, Baharom U and Balter J M 2016 Phantom-based 
characterization of distortion on a magnetic resonance imaging simulator for 
radiation oncology Phys Med Biol 61 774 
Iglesias J E and Sabuncu M R 2015 Multi-atlas segmentation of biomedical images: 
a survey Med Image Anal 24 205-19 
Johnstone E, Wyatt J J, Henry A M, Short S C, Sebag-Montefiore D, Murray L, Kelly 
C G, McCallum H M and Speight R 2018 A systematic review of synthetic CT 
generation methodologies for use in MRI-only radiotherapy Int J Radiat Oncol 
Biol Phys 100 199-217 
Jonsson J H, Karlsson M G, Karlsson M and Nyholm T 2010 Treatment planning 
using MRI data: an analysis of the dose calculation accuracy for different 
treatment regions Radiat Oncol 5 
Kieselmann J P, Kamerling C P, Burgos N, Menten M J, Fuller C D, Nill S, Cardoso 
M J and Oelfke U 2018 Geometric and dosimetric evaluations of atlas-based 
segmentation methods of MR images in the head and neck region Phys Med 
Biol 63 145007 
Kontaxis C, Bol G, Stemkens B, Glitzner M, Prins F, Kerkmeijer L, Lagendijk J and 
Raaymakers B 2017 Towards fast online intrafraction replanning for free-
breathing stereotactic body radiation therapy with the MR-linac Phys Med Biol 
62 7233-48 
Kraus K M, Jäkel O, Niebuhr N I and Pfaffenberger A 2017 Generation of synthetic 
CT data using patient specific daily MR image data and image registration 
Phys Med Biol 62 1358 
Lagendijk J J, Raaymakers B W, Van den Berg C A, Moerland M A, Philippens M E 
and van Vulpen M 2014 MR guidance in radiotherapy Phys Med Biol 59 R349 
Lambrecht M, Melidis C, Sonke J-J, Adebahr S, Boellaard R, Verheij M, 
Guckenberger M, Nestle U and Hurkmans C 2016 Lungtech, a phase II 
EORTC trial of SBRT for centrally located lung tumours–a clinical physics 
perspective Radiat Oncol 11 7 
Longmore M, Wilkinson I, Baldwin A and Wallin E 2014 Oxford handbook of clinical 
medicine: Oxford University Press) 
Menten M J, Fast M F, Nill S, Kamerling C P, McDonald F and Oelfke U 2016 Lung 
stereotactic body radiotherapy with an MR-linac–Quantifying the impact of the 
magnetic field and real-time tumor tracking Radiother Oncol 119 461-6 
Mickevicius N J and Paulson E S 2017 Investigation of undersampling and 
reconstruction algorithm dependence on respiratory correlated 4D-MRI for 
online MR-guided radiation therapy Phys Med Biol 62 2910-21 
Modat M, Ridgway G R, Taylor Z A, Lehmann M, Barnes J, Hawkes D J, Fox N C 
and Ourselin S 2010 Fast free-form deformation using graphics processing 
units Comput Meth Prog Bio 98 278-84 
Mutic S and Dempsey J F 2014 The ViewRay system: magnetic resonance–guided 
and controlled radiotherapy Semin Radiat Oncol 24 196-9 
Ohno Y, Koyama H, Yoshikawa T, Seki S, Takenaka D, Yui M, Lu A, Miyazaki M and 
Sugimura K 2016 Pulmonary high‐resolution ultrashort TE MR imaging: 
Comparison with thin‐section standard‐and low‐dose computed tomography 
for the assessment of pulmonary parenchyma diseases J Magn Reson 
Imaging 43 512-32 
Page 22 of 24AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
c
pte
d M
an
us
c i
pt
4D-sCT for MRgRT 
23 
 
Owrangi A M, Greer P B and Glide-Hurst C K 2018 MRI-only treatment planning: 
benefits and challenges Phys Med Biol 63 05TR1 
Paul J, Divkovic E, Wundrak S, Bernhardt P, Rottbauer W, Neumann H and Rasche 
V 2015 High‐resolution respiratory self‐gated golden angle cardiac MRI: 
comparison of self‐gating methods in combination with k‐t SPARSE SENSE 
Magn Res Med 73 292-8 
Pluim J P, Maintz J A and Viergever M A 2003 Mutual-information-based registration 
of medical images: a survey IEEE T Med Imaging 22 986-1004 
Prior P, Chen X, Gore E, Johnstone C and Li X A 2017 Is Bulk Electron Density 
Assignment Appropriate for MRI‐only Based Treatment Planning for Lung 
Cancer? Med Phys 44 3437-43 
Raaijmakers A, Raaymakers B W and Lagendijk J J 2005 Integrating a MRI scanner 
with a 6 MV radiotherapy accelerator: dose increase at tissue–air interfaces in 
a lateral magnetic field due to returning electrons Phys Med Biol 50 1363 
Raaymakers B, Lagendijk J, Overweg J, Kok J, Raaijmakers A, Kerkhof E, Van Der 
Put R, Meijsing I, Crijns S and Benedosso F 2009 Integrating a 1.5 T MRI 
scanner with a 6 MV accelerator: proof of concept Phys Med Biol 54 N229 
Rank C M, Heußer T, Buzan M T, Wetscherek A, Freitag M T, Dinkel J and 
Kachelrieß M 2017 4D respiratory motion‐compensated image reconstruction 
of free‐breathing radial MR data with very high undersampling Magn Res Med 
77 1170-83 
Rosenblum L J, Mauceri R A, Wellenstein D E, Thomas F D, Bassano D A, Raasch 
B N, Chamberlain C C and Heitzman E R 1980 Density patterns in the normal 
lung as determined by computed tomography Radiology 137 409-16 
Schmidt M A and Payne G S 2015 Radiotherapy planning using MRI Phys Med Biol 
60 R323 
Soejima K, Yamaguchi K, Kohda E, Takeshita K, Ito Y, Mastubara H, Oguma T, 
Inoue T, Okubo Y and Amakawa K 2000 Longitudinal follow-up study of 
smoking-induced lung density changes by high-resolution computed 
tomography Am J Respir Crit Care Me 161 1264-73 
Soille P 1999 Morphological Image Analysis: Springer) pp 229-54 
Stanescu T, Wachowicz K and Jaffray D 2012 Characterization of tissue magnetic 
susceptibility‐induced distortions for MRIgRT Med Phys 39 7185-93 
Stemkens B, Tijssen R H, de Senneville B D, Lagendijk J J and van den Berg C A 
2016 Image-driven, model-based 3D abdominal motion estimation for MR-
guided radiotherapy Phys Med Biol 61 5335-55 
Thwaites D, Keall P, Holloway L, Sykes J and Cosgrove V 2014 Observations on 
MR-LINAC systems and rationale for MR-Linac use: The australian MR-Linac 
project as an example Phys Medica 30 e25 
Wang H, Chandarana H, Block K T, Vahle T, Fenchel M and Das I J 2017 Dosimetric 
evaluation of synthetic CT for magnetic resonance-only based radiotherapy 
planning of lung cancer Radiat Oncol 12 108 
Weygand J, Fuller C D, Ibbott G S, Mohamed A S, Ding Y, Yang J, Hwang K-P and 
Wang J 2016 Spatial Precision in Magnetic Resonance Imaging-Guided 
Radiotherapy: The Role of Geometric Distortion Int J Radiat Oncol 95 1304-
16 
Wolthaus J, Sonke J J, Van Herk M and Damen E 2008a Reconstruction of a time‐
averaged midposition CT scan for radiotherapy planning of lung cancer 
patients using deformable registration Med Phys 35 3998-4011 
Page 23 of 24 AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d
nu
scr
ipt
4D-sCT for MRgRT 
24 
 
Wolthaus J W, Schneider C, Sonke J-J, van Herk M, Belderbos J S, Rossi M M, 
Lebesque J V and Damen E M 2006 Mid-ventilation CT scan construction 
from four-dimensional respiration-correlated CT scans for radiotherapy 
planning of lung cancer patients Int J Radiat Oncol Biol Phys 65 1560-71 
Wolthaus J W, Sonke J-J, van Herk M, Belderbos J S, Rossi M M, Lebesque J V and 
Damen E M 2008b Comparison of different strategies to use four-dimensional 
computed tomography in treatment planning for lung cancer patients Int J 
Radiat Oncol 70 1229-38 
 
 
Page 24 of 24AUTHOR SUBMITTED MANUSCRIPT - PMB-108003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
